Search results
Results From The WOW.Com Content Network
In November 2019, Mylan & Upjohn announced that the name of the new company would be Viatris. [84] [85] The company continued sales of Mylan's more than 7,500 products, including biosimilars, generics, brand and over-the-counter remedies, with brands including the Epi-Pen, Viagra, Lipitor and Celebrex. [86] [87] [88]
After successful lobbying from Mylan, [29] in 2013, the "School Access to Emergency Epinephrine Act" became law after passing Congress with broad and bipartisan support; it protected anyone from liability if they administered epinephrine to a child in a school (previously, only trained professionals or the affected person were allowed to ...
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
The proposed settlement would resolve litigation that began following public outrage in 2016 over Mylan's decision to raise the list price for a pair of EpiPen to $600 from $100 in 2008, fueling a ...
Heather Bresch (née Manchin; born June 27, 1969 [2]) is an American business executive.In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. [3]
After Mylan purchased EpiPen from Merck in 2007, the company raised the price of a two-pack by 500%. The public was furious, but CEO Heather Bresch's bank account is happy and healthy.
The FDA just approved Neffy, a needle-free EpiPen alternative. Here's when it's hitting shelves—and allergists tell 'Women's Health' if they recommend it.
Eleven states created laws to require schools to stock EpiPens, made by Mylan pharmaceuticals, leading to a "near monopoly" of Mylan's epinephrine autoinjector in the school health sector. [8] The article noted the potential for a conflict of interest, as Mylan's CEO, Heather Bresch, is Manchin's daughter.